HIKMA Pharmaceuticals PLC — Director's Dealing 2018

Jun 15, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6054R

Hikma Pharmaceuticals Plc

15 June 2018

Notification and public disclosure of transactions by persons discharging managerial responsibilities

Surendera Tyagi

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Surendera Tyagi
2	Reason for the notification
a)	Position/status	Chief Scientific Officer and Global Head of R&D
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Market purchase of 1,400 Ordinary Shares by IG Markets Limited for and on behalf of Surendera Tyagi.
c)	Price(s) and volume(s)	Price(s): £14.00 Volume(s): 1,400
d)	Aggregated information	Volume: 1,400 Price: £19,600.00
e)	Date of the transaction	14 June 2018
f)	Place of the transaction	London Stock Exchange (XLON)

Peter Speirs

Company Secretary, responsible for releasing this announcement

+44 (0) 20 7399 2760

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHBSGDLDDBBGIU